Enhancement of carcinogen-induced malignant cell transformation by prostaglandin F2α

This publication has 36 references indexed in Scilit:

• The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers
  Carcinogenesis, 1998
• PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
  Genes & Development, 1997
• Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells
  Differentiation, 1996
• Aspirin and the Risk of Colorectal Cancer in Women
  New England Journal of Medicine, 1995
• Effects of Eicosanoid Synthesis Inhibitors on the in vitro Growth and Prostaglandin E and Leukotriene B Secretion of a Human Breast Cancer Cell Line
  Oncology, 1995
• 12-O-Tetradecanoylphorbol-13-acetate and the induction of prostaglandin E₂ generation by human keratinocytes: a re-evaluation
  Carcinogenesis, 1994
• Stimulation of protein kinase C (PKC) activity in resting Swiss 3T3 cells by prostaglandin F_2α
  FEBS Letters, 1992
• A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary turmorigenesis in rats fed different amounts of essential fatty acid
  Carcinogenesis, 1989
• Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion)
  Carcinogenesis, 1989
• Regulation of the immune response by prostaglandins
  Journal of Clinical Immunology, 1983